Recursion Pharmaceuticals  combining -throughput experimental biology, bioinformatics,  machine learning  rapidly identify  indications    drugs  shelved assets.  Their  focus initially    orphan disease space,   core technology  exciting applications  oncology, infectious disease,  inflammation.  Their system     bring  partners shelved assets  market   indications  pennies   dollar compared  traditional drug discovery approaches.
